You have 9 free searches left this month | for more free features.

City

Atlanta (1)

Los Angeles (1)

Portland (1)

Rochester (1)

Condition

Cardiac Disease (1)

Cardiovascular Disease (1)

Hemophilia A (1)

Hemophilia A With Inhibitor (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

phase 3 (1)

phase 4 (1)

Sponsor

Children's Hospital Los Angeles (1)

Emory University (1)

Mayo Clinic (1)

Oregon Health and Science University (1)

Collaborator

Takeda (1)

Takeda Pharmaceuticals North America, Inc. (1)

Intervention

feiba (4)

apcc-emicizumab (1)

normal saline (1)

placebo (1)

rfviia (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Other (4)

Study Type

Interventional (4)

feiba

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Cardiac Disease Trial in Rochester (FEIBA, Placebo)

Recruiting

Cardiac Disease

FEIBA
Placebo

Rochester, Minnesota

Mayo Clinic in Rochester

Nov 30, 2021

Hemophilia A With Inhibitor Trial in Los Angeles (Feiba)

Active, not recruiting

Hemophilia A With Inhibitor

Feiba

Los Angeles, California

Childrens Hospital Los Angeles

Mar 7, 2022

Hemophilia A Trial in Atlanta (aPCC-emicizumab, FEIBA, rFVIIa)

Not yet recruiting

Hemophilia A

aPCC-emicizumab
+2 more

Atlanta, Georgia
+1 more

Jan 5, 2023

Cardiovascular Disease Trial in Portland (FEIBA, Normal Saline)

Completed

Cardiovascular Disease

FEIBA
Normal Saline

Portland, Oregon

Oregon Health and Science University

Jul 13, 2020